Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.76847 | 32 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.7465 | 33 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.7515 | 33 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.71149 | 34 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.7031 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.81071 | 32 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.22301 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.72972 | 33 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.73095 | 33 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.73581 | 33 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.73088 | 33 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.71501 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.07972 | 46 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.74342 | 33 |